The Chemours Company (NYSE:CC – Get Free Report) has earned an average rating of “Hold” from the twelve research firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $24.60.
Several brokerages have recently issued reports on CC. The Goldman Sachs Group raised their price objective on Chemours from $14.00 to $18.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 25th. Morgan Stanley raised their price objective on Chemours from $17.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Monday, May 11th. Jefferies Financial Group restated a “hold” rating and issued a $17.00 price objective on shares of Chemours in a research note on Monday, February 23rd. Weiss Ratings restated a “sell (d)” rating on shares of Chemours in a research note on Monday, April 20th. Finally, Royal Bank Of Canada raised their price objective on Chemours from $26.00 to $29.00 and gave the stock an “outperform” rating in a research note on Monday, May 11th.
Get Our Latest Stock Report on CC
Institutional Inflows and Outflows
Chemours Price Performance
Shares of NYSE CC opened at $20.46 on Friday. The company has a debt-to-equity ratio of 18.98, a quick ratio of 0.87 and a current ratio of 1.82. The company has a market cap of $3.08 billion, a PE ratio of -7.75 and a beta of 1.39. The business has a 50-day simple moving average of $23.11 and a two-hundred day simple moving average of $18.02. Chemours has a fifty-two week low of $10.14 and a fifty-two week high of $28.67.
Chemours (NYSE:CC – Get Free Report) last issued its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $0.05 earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.10. The business had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.40 billion. Chemours had a positive return on equity of 52.49% and a negative net margin of 6.82%.The company’s quarterly revenue was up 1.0% on a year-over-year basis. During the same quarter last year, the company earned $0.13 earnings per share. As a group, equities analysts expect that Chemours will post 1.27 EPS for the current fiscal year.
Chemours Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 16th. Stockholders of record on Sunday, May 17th will be paid a $0.0875 dividend. This represents a $0.35 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Friday, May 15th. Chemours’s dividend payout ratio (DPR) is presently -13.26%.
About Chemours
Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.
Chemours’ principal business activities are organized into three core segments.
See Also
- Five stocks we like better than Chemours
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.
